Lunai Bioworks (LNAI) Asset Utilization Ratio (2016 - 2026)

Lunai Bioworks (LNAI) posted quarterly Asset Utilization Ratio of 0.01 for Q1 2026, down 90.04% quarter-over-quarter from 0.1 in Q2 2016.

Lunai Bioworks (LNAI) Asset Utilization Ratio (2016 - 2026) Analysis & Trends

Lunai Bioworks' Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.01 for Q1 2026.

In Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (changed N/A YoY), while the FY2016 annual figure was 0.04, changed N/A from the prior year.
Asset Utilization Ratio for Q1 2026 stood at 0.01, down from 0.1 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.01 in Q1 2026, with the low at 0.01 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.54 Bn	130.69 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.89 Bn	77.89 Bn	3.93 Bn	0.38
3	Argenx Se	64.84 Bn	59.65 Bn	1.37 Bn	-
4	Moderna	56.53 Bn	51.39 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.97 Bn	36.87 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.53 Bn	28.22 Bn	992.69 Mn	0.90
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn	0.13
8	Insmed	27.45 Bn	26.29 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	0.13
10	Lunai Bioworks	6.87 Mn	3.72 Mn	20,942.00	0.01

Download Data

Date	Value
Mar 31, 2026	0.01
Jun 30, 2016	0.10